Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer

Kei Miyamoto, Naohiko Seki, Ryo Matsushita, +4

British Journal of Cancer

Dual tumor‐suppressors <i>miR‐139‐5p</i> and <i>miR‐139‐3p</i> targeting <i>matrix metalloprotease 11</i> in bladder cancer

Masaya Yonemori, Naohiko Seki, Hirofumi Yoshino, +4

Cancer Science

Regulation of<i>UHRF1</i>by dual-strand tumor-suppressor<i>microRNA-145</i>(<i>miR-145-5p</i>and<i>miR-145-3p</i>): inhibition of bladder cancer cell aggressiveness

Ryosuke Matsushita, Hirofumi Yoshino, Hideki Enokida, +6

Oncotarget

PHGDH as a Key Enzyme for Serine Biosynthesis in HIF2α-Targeting Therapy for Renal Cell Carcinoma

Hirofumi Yoshino, Nijiro Nohata, Kazutaka Miyamoto, +8

Cancer Research

microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma

Hirofumi Yoshino, Masaya Yonemori, Kazutaka Miyamoto, +5

Oncotarget

Crispr/cas9 GeneTumor BiologyGenitourinary CancerCancer Cell BiologyRenal Cell Carcinoma +14

Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer

Takashi Sakaguchi, Hirofumi Yoshino, Masaya Yonemori, +7

British Journal of Cancer

EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer

Shunsuke Okamura, Hirofumi Yoshino, Kazuki Kuroshima, +8

BMC Cancer

Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer

Atsushi Okato, Yusuke Goto, Akira Kurozumi, +7

International Journal of Oncology

Naïve PcaCancer BiologyTumor BiologyCancer Cell BiologyRadiation Oncology +17

Potential tumor‑suppressive role of microRNA‑99a‑3p in sunitinib‑resistant renal cell carcinoma cells through the regulation of RRM2

Yoichi Osako, Hirofumi Yoshino, Takashi Sakaguchi, +4

International Journal of Oncology

Renal InflammationPathologyCancer BiologyTumor BiologyOther Rcc Cells +16

HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer

Satoshi Sugita, Hideki Enokida, Hirofumi Yoshino, +5

International Journal of Oncology

PathologyPharmacotherapyCancer BiologyTumor BiologyGenitourinary Cancer +18